New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free

LL-37

Also known as: Cathelicidin, hCAP18, Antimicrobial Peptide LL-37

LL-37 is the only known human cathelicidin antimicrobial peptide. It kills bacteria, fungi, and viruses by disrupting their membranes, while simultaneously modulating immune responses. Used for antimicrobial protection, immune priming, and wound healing.

Half-Life

Very short (~1–2 hours) in plasma due to protease degradation; topical use bypasses systemic clearance

Route

SubQ, Topical, Intranasal

Category

Immune Support, Recovery & Repair

Studies

50 references

Key Benefits

  • Broad-spectrum antimicrobial (bacteria, fungi, viruses)
  • Promotes wound healing and angiogenesis
  • Immune system modulation — enhances innate immunity
  • Reduces LPS-mediated endotoxemia
  • Anti-biofilm activity against resistant organisms
  • Promotes tissue regeneration and keratinocyte migration
  • May protect against sepsis

Mechanism of Action

LL-37 is derived from the C-terminus of the human cathelicidin protein hCAP18. It inserts into microbial cell membranes causing pore formation and membrane disruption. Additionally it acts as a GPCR ligand (FPRL1/FPR2), Toll-like receptor modulator, and can bind and neutralize lipopolysaccharide (LPS), preventing endotoxin-mediated inflammation. In host cells it promotes keratinocyte migration, angiogenesis, and wound closure.

Dosing Protocols

Immune Support / Systemic

Dose
100–300 mcg
Frequency
2–3x per week
Timing
SC injection
Cycle
4–8 weeks

Cycle off periodically to avoid immune desensitization

Wound Healing (Topical)

Dose
Apply liberally to wound
Frequency
1–2x daily
Timing
After cleaning wound
Cycle
Until healed

Use at 0.1–1% concentration

Calculate your draw volume

Enter your vial size and BAC water to get exact injection volumes

Calculate dose →

Side Effects

  • Injection site redness and irritation
  • Mild inflammatory response at injection site
  • Potential pro-inflammatory at high doses
  • Rare: fever or flu-like symptoms at initiation

Contraindications

Use with caution in autoimmune conditions. High doses may paradoxically increase inflammation. Not recommended during acute cytokine storm.

Storage

Lyophilized: store at -20°C. Reconstituted: 4°C, use within 2–4 weeks. Protect from light and repeated freeze-thaw cycles.

  1. 1.
    Analysis of Antimicrobial Peptide Expression Under Acute and Chronic Alcohol Exposure: A Cross-Sectional Study and a Systematic Review of the Literature

    Rojas-Pirela M, Herrera-Flores C, Costa-Alba P, Salete-Granado D, Aguilar ML, Puertas-Miranda D et al. · International journal of molecular sciences · 2026PubMed Verified

  2. 2.
    Host Defense Antimicrobial Peptides (HDPs) as Regulators of Hemostasis and Vascular Biology

    Aguilar-Ruiz SR, Sánchez-Peña FJ, Rodríguez-Magadán HM, Domínguez-Martínez MA, Bernardino-Hernández HU, Aquino-Domínguez AS · Biomolecules · 2026ReviewPubMed Verified

  3. 3.
  4. 4.
    Investigation of Regulation and Binding Patterns of the Human Cathelicidin Peptide LL-37 in Complexation with Nucleic Acids, and its Impact on Neutrophil Extracellular Traps

    Zielke C, Rad B, Nielsen JE, Li J, Pimcharoen S, Sawant M et al. · bioRxiv : the preprint server for biology · 2026PubMed Verified

  5. 5.
    Modulation of LPS-associated virulence activity for reduction of periodontal inflammatory burden

    Dong A, Lehto M, Putaala J, Paju S, Pussinen P, Zaric S · Frontiers in microbiology · 2026PubMed Verified

  6. 6.
    Disturbed regulation of immunothrombosis in cerebral ischemia associated with SARS-CoV-2 infection

    Plem R, de Buhr N, Imker R, Akhdar S, Meurer M, Falk CS et al. · Frontiers in immunology · 2026PubMed Verified

  7. 7.
    Common Biomarkers in Chronic Obstructive Pulmonary Disease and Bronchopulmonary Dysplasia: A Narrative Review of an Intriguing Interplay

    Gambadauro A, Xerra F, Chirico V, Rulli I, Cacciola A, Mallamace R et al. · International journal of molecular sciences · 2026ReviewPubMed Verified

  8. 8.
    Immunomodulatory Effects of the Antimicrobial Peptide KR-20: Implications for Trichomoniasis

    Ramírez-Ledesma MG, Ávila EE, Alva-Murillo N · Molecules (Basel, Switzerland) · 2026PubMed Verified

  9. 9.
    Fever enhances host bacterial defense while limiting mitochondrial damage

    Gross S, Wu Y, Rowe E, Siryaporn A · Research square · 2026PubMed Verified

  10. 10.
    Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer

    Le Fournis C, Maszota-Zieleniak M, Kulesza A, Chopra P, Boons GJ, Aubrey N et al. · Glycobiology · 2026PubMed Verified

  11. 11.
    Lithospermic acid, a novel KLK5 inhibitor, ameliorates rosacea by suppressing the TLR4/NF-κB signaling pathway and rectifying phenylalanine metabolism

    Xu J, Wang X, Chen M, Xu B, Zhang T, Zhang Y et al. · Frontiers in immunology · 2026PubMed Verified

  12. 12.
    Markov State Models Reveal How hLL-37(17-29) Tetramers Relax from a Disordered State to a Cross-α Amyloid Geometry

    Mitra A, Paul S · The journal of physical chemistry. B · 2026PubMed Verified

  13. 13.
    Evaluation of the relationship between salivary levels of Streptococcus mutans, statherin, and cathelicidin LL-37 and early childhood caries

    Pamuk C, Ersin N, Emingil G, Ozdemir G, Vural C, Vural C et al. · BMC oral health · 2026PubMed Verified

  14. 14.
    Limosilactobacillus fermentum LF61: A multidimensional study on safety and functionality from genomics to clinical application

    Jin M, Xu F, Liu Y, Jiang Z · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2026PubMed Verified

  15. 15.
    CRISPR/Cas9-engineered Salmonella phage displaying antimicrobial peptide LL37 for enhanced antibacterial activity

    Jo SJ, Park SC, Kim SG · International journal of antimicrobial agents · 2026PubMed Verified

  16. 16.
    Injectable self-healing hydrogel loaded with a self-assembling LL-37 derivative for treating infected skin wounds

    Ba Q, Yao J, Tian H, Meng Y, Kong Y, Jia Y et al. · International journal of pharmaceutics · 2026PubMed Verified

  17. 17.
    A pH-Triggered antibacterial and lubricating dual-function hydrogel coating for infection-resistant urinary catheters

    Cheng M, Lin W, Yu J, Gao P, Shi F, Wang C et al. · Frontiers in bioengineering and biotechnology · 2026PubMed Verified

  18. 18.
    Advances in the pathogenesis of rosacea

    Wang H, Zhou C · Frontiers in immunology · 2025ReviewPubMed Verified

  19. 19.
    Regulation of virulence factors of Pseudomonas aeruginosa by Scutellaria baicalensis, Prunella vulgaris and antimicrobial peptide LL-37

    Xiao Q, Du K, Luo L, Luo Y, Wu X, Zhao C et al. · Journal of medical microbiology · 2026PubMed Verified

  20. 20.
    Exploring mesenchymal stem cells as a novel therapeutic approach for HACEK endocarditis: a narrative review

    Kodori M, Farhadi N, Jafari GA, Afkhami H, Yousefi MH · Journal of cardiothoracic surgery · 2026ReviewPubMed Verified

  21. 21.
    Dermofunctional Vehicle Downregulates LL-37 and MMPs and Upregulates IGFBP-3

    Polonini H, da Silva Olímpio FR, Oliveira CR · Current issues in molecular biology · 2025PubMed Verified

  22. 22.
    New SufA Protease Inhibitors and Activity-based Probes: Design, Synthesis, and Antibacterial Activity Assessment

    Burchacka E, Postawa K, Pięta P · Current medicinal chemistry · 2026PubMed Verified

  23. 23.
    The multifaceted role of antimicrobial peptides in neurodegeneration: Insights from Drosophila and beyond

    Behera P, Rangappa N, Chandrashekar M, Mishra A, Chinnathambi S, Mishra M · Advances in protein chemistry and structural biology · 2026ReviewPubMed Verified

  24. 24.
    Antimicrobial peptides inhibit Tau aggregation and modulates its pathology

    Chinnathambi S, Rangappa N, Malik S · Advances in protein chemistry and structural biology · 2026ReviewPubMed Verified

  25. 25.
    Structural insights, immunomodulatory functions, and therapeutic potential of host defense peptides in avoiding antimicrobial resistance

    Rodrigues GR, Leite ML, Franco OL · Advances in protein chemistry and structural biology · 2026ReviewPubMed Verified

  26. 26.
    Increased cathelicidin LL-37 colonic expression is associated with tumor progression in colorectal cancer

    Wlodarczyk J, Dziki L, Fichna J · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2025PubMed Verified

  27. 27.
    Epithelial Heparan Sulfate Promotes Staphylococcus aureus Corneal Infection by Inhibiting Cathelicidins

    Hayashida K, Esko JD, Gallo RD, Liu J, Kao WW, Park PW · Proteoglycan research · 2025PubMed Verified

  28. 28.
    LL-37 antimicrobial peptide: Molecular characterisation and its role in oral health and disease-A narrative review

    Soman D, P J, Cm M, Radhakrishnan R · Archives of oral biology · 2026ReviewPubMed Verified

  29. 29.
    Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients

    Dhaffouli F, Elloumi N, Sellami K, Bahloul E, Tahri S, Turki H et al. · Anais brasileiros de dermatologia · 2026PubMed Verified

  30. 30.
  31. 31.
    Single Amino Acid Modulates Antimicrobial Peptide Cooperativity between LL-37 and HNP1

    Schwitter AM, Yasuda T, Li X, Sugihara K · Langmuir : the ACS journal of surfaces and colloids · 2026PubMed Verified

  32. 32.
    LL-37 and citrullinated-LL-37 enhances oxylipins: citrullination attenuates LL-37-mediated COX-2-dependent chemokine response in human bronchial epithelial cells

    Ramotar P, Hemshekhar M, Altieri A, M van der Does A, Pascoe CD, Mookherjee N · Respiratory research · 2026PubMed Verified

  33. 33.
    α-Helical Peptides Encoded in Collagen Exhibit Antimicrobial Activity with Low Cytotoxicity

    Jarmusch SA, Muhammad T, Göransson U, Strömstedt AA · Journal of natural products · 2026PubMed Verified

  34. 34.
  35. 35.
    Unveiling balanced prenatal microbial colonization in amniotic fluid through an integrated culture and sequencing approach

    González-Rovira M, Sainz-Bueno JA, García-Díaz L, Martínez-Pancorbo C, Sánchez J, Gutiérrez G et al. · Journal of translational medicine · 2026PubMed Verified

  36. 36.
    SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting

    Zhang Y, Silvestre-Roig C, Fu H, Alimohamadi H, Mandal T, Chen JW et al. · Proceedings of the National Academy of Sciences of the United States of America · 2026PubMed Verified

  37. 37.
    Microbiota modulation by a human Paneth cell α-defensin fragment protects against DSS-induced colitis

    Bonazzi E, Hao F, Patterson AD, Peyrin-Biroulet L, Jensen BAH, Chassaing B · iScience · 2026PubMed Verified

  38. 38.
    Immunomodulatory effects of cathelicidin in the gut-brain axis: A novel link between mucosal immunity and neuroinflammation

    Nourizadeh M, Ghahari AA, Zandi E, Rasouli SZ, Davari S, Hoseinzadeh M et al. · Experimental physiology · 2026ReviewPubMed Verified

  39. 39.
    LL-37-derived peptide shows promising antimicrobial potential against multidrug-resistance pathogens

    Asmamaw D, Cai H, Prateeksha P, Khalid M, Mwangi J, Yi W et al. · European journal of medicinal chemistry · 2026PubMed Verified

  40. 40.
    Extended-Spectrum β-Lactamase-Producing Escherichia coli and Pediatric UTIs: A Review of the Literature and Selected Experimental Observations

    Tamas V, Ulloa ER, Kumaraswamy M, Dahesh S, Zurich R, Nizet V et al. · Antibiotics (Basel, Switzerland) · 2025ReviewPubMed Verified

  41. 41.
    Differences in Inflammatory Genetic Profiles in Periodontitis Associated with Genetic and Immunological Disorders: A Systematic Review

    Astolfi-Labrador L, Cabezas-Corado Á, Torres-Lagares D, Baus-Domínguez M · Biomedicines · 2025ReviewPubMed Verified

  42. 42.
  43. 43.
    LL-37 as a biomarker for therapeutic response to scaling and root planing

    Rao KS, Yadalam PK, Ravishankar PL, Rajula PB, Ravikumar H, Arunraj DR · Journal of Indian Society of Periodontology · 2025PubMed Verified

  44. 44.
    The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease

    Barron AE, Lin JS, Ryder MI, Bergman P · Journal of internal medicine · 2026ReviewPubMed Verified

  45. 45.
    Pneumococcal S protein coordinates cell wall modification and repair to resist host antimicrobials

    Burnier J, Gallay C, Bruce KE, Bjånes E, Martin L, Jim KK et al. · Nature microbiology · 2026PubMed Verified

  46. 46.
    Synthetic antimicrobial peptide LD4-PP protects the host against E. coli-induced cell death

    Mohanty S, White JK, Yin Y, Muhammad T, Demirel I, Strömstedt AA et al. · Frontiers in immunology · 2025PubMed Verified

  47. 47.
    Dissolving microneedle co-deliver mitochondria-targeted Nanozyme and Tofacitinib for synergistic treatment of Rosacea

    Huang Y, Lu W, Hu J, Lang J, Zhu Q, Zhu J et al. · Journal of controlled release : official journal of the Controlled Release Society · 2026PubMed Verified

  48. 48.
    Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis

    Yakobi SH, Nwodo UU · Current research in structural biology · 2025PubMed Verified

  49. 49.
    Convergence of plasmid-driven virulence and antibiotic resistance in Escherichia coli

    Lian ZJ, Nhu NTK, Ravi C, Chang C, Martinez-Roman I, Phan MD et al. · Nature communications · 2025PubMed Verified

  50. 50.
    LL-37-biofunctionalized titanium improves soft tissue seal surrounding the dental implant from the perspective of optimizing a race to the surface

    Li Y, Huang J, Zhang Y, He Y, Cai D, Xu M et al. · Regenerative biomaterials · 2025PubMed Verified

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice. Many compounds listed are research chemicals not approved for human use. Always consult a qualified healthcare professional before starting any protocol.

Was this page helpful?

Launching soon

Build and track your protocol in Staqk

Log doses, track timing, monitor biomarkers, and manage every compound in your stack — all in one place.

Free early access updates. No spam.